0001213900-22-041449.txt : 20220726 0001213900-22-041449.hdr.sgml : 20220726 20220725215032 ACCESSION NUMBER: 0001213900-22-041449 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20220725 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20220726 DATE AS OF CHANGE: 20220725 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Waldencast Acquisition Corp. CENTRAL INDEX KEY: 0001840199 STANDARD INDUSTRIAL CLASSIFICATION: PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844] IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40207 FILM NUMBER: 221104774 BUSINESS ADDRESS: STREET 1: 10 BANK STREET, SUITE 560 CITY: WHITE PLAINS STATE: NY ZIP: 10606 BUSINESS PHONE: (917) 546-6828 MAIL ADDRESS: STREET 1: 10 BANK STREET, SUITE 560 CITY: WHITE PLAINS STATE: NY ZIP: 10606 8-K 1 ea163327-8k425_walden.htm CURRENT REPORT
0001840199 false 0001840199 2022-07-25 2022-07-25 0001840199 WALD:UnitsEachConsistingOfOneClassOrdinaryShareParValue0.0001AndOnethirdOfOneRedeemableWarrantMember 2022-07-25 2022-07-25 0001840199 WALD:ClassOrdinarySharesParValue0.0001PerShareMember 2022-07-25 2022-07-25 0001840199 WALD:RedeemableWarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50Member 2022-07-25 2022-07-25 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): July 25, 2022

 

 

 

Waldencast Acquisition Corp.

(Exact name of registrant as specified in its charter)

 

 

 

Cayman Islands   001-40207   98-1575727
(State or other jurisdiction   (Commission   (I.R.S. Employer
of incorporation)   File Number)   Identification No.)

 

10 Bank Street, Suite 560    
White Plains, New York   10606
(Address of principal executive offices)   (Zip Code)

 

(917) 546-6828

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☒Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Units, each consisting of one Class A ordinary share, par value $0.0001, and one-third of one redeemable warrant   WALDU   The Nasdaq Stock Market LLC
Class A ordinary shares, par value $0.0001 per share   WALD   The Nasdaq Stock Market LLC
Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50   WALDW   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

 

Waldencast plc. 2022 Incentive Award Plan

 

At the Extraordinary General Meeting (the “Extraordinary General Meeting”) of shareholders of Waldencast Acquisition Corp. (“Waldencast” or the “Company” and, after the Domestication (as defined below) and the Business Combination (as defined below), “Waldencast plc”), Waldencast’s shareholders approved by ordinary resolution and adopted the Waldencast plc. 2022 Incentive Award Plan (the “2022 Plan”). The 2022 Plan was previously approved, subject to shareholder approval by the Board of Directors of Waldencast on June 10, 2022.

 

The 2022 Plan provides for the grant of incentive stock options, nonstatutory options, restricted stock, restricted stock units, stock appreciation rights, dividend equivalents, other stock-based awards, performance awards, cash awards or any combination of the foregoing, to certain of Waldencast plc’s or its affiliates’ officers, employees, non-employee directors and consultants.

 

The maximum number of shares of common stock, par value $0.0001 per share, of Waldencast plc initially reserved and available for issuance under the 2022 Plan is equal to fifteen percent (15%) of the fully diluted Waldencast plc common stock immediately following consummation of the Business Combination, all of which are available for issuance pursuant to incentive stock options under Section 422 of the U.S. Internal Revenue Code of 1986, as amended, or as other types of awards. In addition, the number of shares of Waldencast plc common stock reserved for issuance under the 2022 Plan will automatically increase on January 1st of each calendar year (each, an “Evergreen Date”), starting on January 1, 2023 and ending prior to the tenth anniversary of the Effective Date (as such term is defined in the 2022 Plan), in an amount equal to the lesser of (i) three percent (3%) of the fully diluted shares of Waldencast plc common stock issued and outstanding on the December 31st immediately preceding the applicable Evergreen Date and (ii) a number of shares of Waldencast plc common stock determined by the board of directors of Waldencast plc prior to the date of the increase, including zero.

 

The 2022 Plan is described in greater detail in Waldencast’s definitive proxy statement/prospectus (the “Definitive Proxy”) for the Extraordinary General Meeting filed with the U.S. Securities and Exchange Commission on July 6, 2022 and is incorporated herein by reference. That summary and the foregoing description of the 2022 Plan do not purport to be complete and are qualified in all respects by the full text of the 2022 Plan included as Annex J to the Definitive Proxy. Any capitalized terms not defined herein have the meaning ascribed to them in the Definitive Proxy.

 

Item 5.07 Submission of Matters to a Vote of Security Holders

 

At the Extraordinary General Meeting, holders of 30,215,597 Waldencast’s ordinary shares, which represented 70.06% of the ordinary shares outstanding and entitled to vote as of the record date of May 27, 2022, were represented in person or by proxy. The final voting results for each matter submitted to a vote of the Waldencast shareholders at the Extraordinary General Meeting are set forth below:

 

Approval of the Obagi Merger Proposal

 

Waldencast’s shareholders approved by ordinary resolution and adopted the Agreement and Plan of Merger, dated as of November 15, 2021 (the “Obagi Merger Agreement”), by and among Waldencast, Obagi Merger Sub, Inc., a Cayman Islands exempted company limited by shares and an indirect wholly owned subsidiary of Waldencast (“Merger Sub”), and Obagi Global Holdings Limited, a Cayman Islands exempted company limited by shares (“Obagi”), which provides for, among other things, the merger of Merger Sub with and into Obagi (the “Obagi Merger”), with Obagi surviving the Obagi Merger as a wholly owned subsidiary of Waldencast, in accordance with the terms and subject to the conditions of the Obagi Merger Agreement (the “Obagi Merger Proposal”). The voting results with respect to the Obagi Merger Proposal were as follows:

 

Votes For  Votes Against  Abstentions  Broker Non-Votes
29,628,733  586,864  0  0

 

1

 

 

Approval of the Milk Transaction Proposal

 

Waldencast’s shareholders approved by ordinary resolution and adopted the Equity Purchase Agreement, dated as of November 15, 2021 (the “Milk Equity Purchase Agreement”), by and among Waldencast, Obagi Holdco 1 Limited, a limited company incorporated under the laws of Jersey (“Holdco Purchaser”), Waldencast Partners LP, a Cayman Islands exempted limited partnership (“Waldencast LP” and together with Holdco Purchaser, the “Milk Purchasers”), Milk Makeup LLC, a Delaware limited liability company (“Milk”), certain members of Milk (the “Milk Members”), and Shareholder Representative Services LLC, a Colorado limited liability company, solely in its capacity as representative of Milk’s equityholders (the “Equityholder Representative”), which provides for, among other things, the Milk Purchasers shall acquire from the Milk Members, and the Milk Members shall sell to the Milk Purchasers, all of the issued and outstanding membership interests of Milk in exchange for the Milk Cash Consideration, the Milk Equity Consideration and the Waldencast plc Non-Economic ordinary shares, in accordance with the terms and subject to the conditions of the Milk Equity Purchase Agreement (the “Milk Transaction Proposal” and, together with the Obagi Merger Proposal, the “BCA Proposal”). The voting results with respect to the Milk Transaction Proposal were as follows:

 

Votes For  Votes Against  Abstentions  Broker Non-Votes
29,578,733  586,864  50,000  0

 

Approval of the Domestication Proposal

 

Waldencast’s shareholders approved by special resolution the change of Waldencast’s jurisdiction of incorporating by de-registering as an exempted company in the Cayman Islands pursuant to section 206 of the Companies Act and Article 47 of the Amended and Restated Articles of Association of Waldencast (as amended) and continuing and domesticating as a public limited company incorporated under the laws of Jersey (the “Domestication” and, together with the Obagi Merger and the Milk Transaction, the “Business Combination”) (the “Domestication Proposal”). The voting results with respect to the Domestication Proposal were as follows:

 

Votes For  Votes Against  Abstentions  Broker Non-Votes
29,628,733  586,864  0  0

 

Organizational Documents Proposals

 

Waldencast’s shareholders approved the following material differences between Waldencast’s Amended and Restated Memorandum and Articles of Association (as may be amended from time to time, the “Cayman Constitutional Documents”) and the proposed new memorandum and articles of association (“Proposed Constitutional Documents”) of Waldencast Acquisition Corp (a corporation incorporated in Jersey, and the filing with and acceptance by the Registrar of Companies of Jersey of the Proposed Constitutional Documents, and the necessary accompanying documents, in accordance with Jersey Companies Law), which will be renamed “Waldencast plc” in connection with the Business Combination:

 

Approval of Organizational Documents Proposal A

 

Waldencast’s shareholders approved by special resolution the change in the authorized share capital of the Company from US$55,500 divided into (i) 500,000,000 Class A ordinary shares, par value $0.0001 per share, (ii) 50,000,000 Class B ordinary shares, par value $0.0001 per share, and (iii) 5,000,000 preferred shares, par value $0.0001 per share to US$112,500 divided into (i) 1,000,000,000 Waldencast plc Class A ordinary shares, par value $0.0001 per share, (ii) 100,000,000 Waldencast plc Class B ordinary shares, par value $0.0001 per share, and (iii) 25,000,000 Waldencast plc preference shares, par value $0.0001 per share (“Organizational Documents Proposal A”). The voting results with respect to Organizational Documents Proposal A were as follows:

 

Votes For  Votes Against  Abstentions  Broker Non-Votes
29,578,724  586,873  50,000  0

 

2

 

 

Approval of Organizational Documents Proposal B

 

Waldencast’s shareholders approved by ordinary resolution that the Waldencast plc Board be divided into three classes, with each class made up of, as nearly as may be possible, one-third of the total number of directors constituting the entire Waldencast plc Board, with only one class of directors being elected in each year and each class serving a three-year term (“Organizational Documents Proposal B”). The voting results with respect to Organizational Documents Proposal B were as follows:

 

Votes For  Votes Against  Abstentions  Broker Non-Votes
29,553,683  611,864  50,050  0

 

Approval of Organizational Documents Proposal C

 

Waldencast’s shareholders approved by ordinary resolution that certain provisions of the Proposed Constitutional Document of Waldencast will be subject to the proposed new Investor Rights Agreement, as defined in the Definitive Proxy, including provisions governing the appointment, removal and replacement of directors, with respect to which Cedarwalk Skincare Ltd. will have certain rights pursuant to the Investor Rights Agreement (“Organizational Documents Proposal C”). The voting results with respect to Organizational Documents Proposal C were as follows:

 

Votes For  Votes Against  Abstentions  Broker Non-Votes
29,553,683  586,864  75,050  0

 

Approval of Organizational Documents Proposal D

 

Waldencast’s shareholders by special resolution the amendment and restatement of the Cayman Constitutional Documents by their deletion in their entirety and the substitution in their place of the Proposed Constitutional Document, including all other changes to the Cayman Constitutional Documents as set out in the Proposed Constitutional Document, in addition to such principal changes as described in Organizational Documents Proposals A-C, including (1) changing the corporate name from “Waldencast Acquisition Corp.” to “Waldencast plc”, (2) making Waldencast plc’s existence for an unlimited duration and (3) removing certain provisions related to Waldencast plc’s status as a blank check company that will no longer be applicable upon consummation of the Business Combination (“Organizational Documents Proposal D”). The voting results with respect to Organizational Documents Proposal D were as follows:

 

Votes For  Votes Against  Abstentions  Broker Non-Votes
29,578,733  586,864  50,000  0

 

Approval of the Director Election Proposal

 

Waldencast’s shareholders approved by ordinary resolution of the holders of Waldencast Class B shares, the election of the persons named below to serve on the Waldencast plc Board upon the consummation of the Business Combination in the classes set forth below:

 

Name of Director / Class

 

Sarah Brown – Class I

 

Lindsay Pattison – Class I

 

Zack Werner – Class I

 

Aaron Chatterley – Class II

 

Juliette Hickman – Class II

 

Cristiano Souza – Class II

 

Michel Brousset – Class III

 

Simon Dai – Class III

 

Felipe Dutra – Class III

 

(the “Director Election Proposal”).

 

3

 

 

The voting results with respect to the election of Sarah Brown were as follows:

 

Votes For  Votes Against  Abstentions  Broker Non-Votes
8,625,000  0  0  0

 

The voting results with respect to the election of Lindsay Pattison were as follows:

 

Votes For  Votes Against  Abstentions  Broker Non-Votes
8,625,000  0  0  0

 

The voting results with respect to the election of Zack Werner were as follows:

 

Votes For  Votes Against  Abstentions  Broker Non-Votes
8,625,000  0  0  0

 

The voting results with respect to the election of Aaron Chatterley were as follows:

 

Votes For  Votes Against  Abstentions  Broker Non-Votes
8,625,000  0  0  0

 

The voting results with respect to the election of Juliette Hickman were as follows:

 

Votes For  Votes Against  Abstentions  Broker Non-Votes
8,625,000  0  0  0

 

The voting results with respect to the election of Cristiano Souza were as follows:

 

Votes For  Votes Against  Abstentions  Broker Non-Votes
8,625,000  0  0  0

 

The voting results with respect to the election of Michel Brousset were as follows:

 

Votes For  Votes Against  Abstentions  Broker Non-Votes
8,625,000  0  0  0

 

The voting results with respect to the election of Simon Dai were as follows:

 

Votes For  Votes Against  Abstentions  Broker Non-Votes
8,625,000  0  0  0

 

The voting results with respect to the election of Felipe Dutra were as follows:

 

Votes For  Votes Against  Abstentions  Broker Non-Votes
8,625,000  0  0  0

 

4

 

 

Approval of the Stock Issuance Proposal

 

Waldencast’s shareholders approved by ordinary resolution, for the purposes of complying with the applicable provisions of Rule 5635 of the Nasdaq Rules, the issuance of (a) Waldencast plc Class A ordinary shares pursuant to the PIPE Investment and the Obagi Merger Agreement, and (b) Waldencast plc units pursuant to the Forward Purchase Transaction (the “Stock Issuance Proposal”). The voting results with respect to the Stock Issuance Proposal were as follows:

 

Votes For  Votes Against  Abstentions  Broker Non-Votes
29,578,733  586,864  50,000  0

 

Approval of the Milk Issuance Proposal

 

Waldencast’s shareholders approved by ordinary resolution, for the purposes of complying with the applicable provisions of Rule 5636 of the Nasdaq Rules, the issuance and reservation of Waldencast plc Class A ordinary shares and Waldencast plc Non-Economic ordinary shares pursuant to the Milk Equity Purchase Agreement (collectively, the “Milk Issuance Proposal”). The voting results with respect to the Milk Issuance Proposal were as follows:

 

Votes For  Votes Against  Abstentions  Broker Non-Votes
29,578,733  586,864  50,000  0

 

Approval of the Incentive Award Plan Proposal

 

Waldencast’s shareholders approved by ordinary resolution the 2022 Plan (the “Incentive Award Plan Proposal”). The voting results with respect to the Incentive Award Plan Proposal were as follows:

 

Votes For  Votes Against  Abstentions  Broker Non-Votes
29,553,183  587,364  75,050  0

 

Approval of the Adjournment Proposal

 

Waldencast’s shareholders approved by ordinary resolution the adjournment of the Extraordinary General Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event that there are insufficient votes for the approval of one or more proposals at the Extraordinary General Meeting (the “Adjournment Proposal”). The voting results with respect to the Adjournment Proposal were as follows:

 

Votes For  Votes Against  Abstentions  Broker Non-Votes
29,323,461  842,136  50,000  0

 

Though not guaranteed, Waldencast expects to close the Business Combination on or about July 27, 2022, subject to the satisfaction or waiver of customary closing conditions, and for the New Waldencast common stock and warrants to begin publicly trading on The Nasdaq Capital Market under the new symbols “WALD” and “WALDW”, respectively, following the Closing.

 

5

 

 

Item 7.01 Regulation FD Disclosure.

 

On July 25, 2022, Waldencast issued a press release announcing the results of the Extraordinary General Meeting and related matters. A copy of the press release is furnished as Exhibit 99.1 hereto and incorporated by reference herein.

 

The information in this Item 7.01, including Exhibit 99.1, is furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to liabilities under that section, and shall not be deemed to be incorporated by reference into the filings of Waldencast under the Securities Act or the Exchange Act, regardless of any general incorporation language in such filings. This Current Report on Form 8-K will not be deemed an admission as to the materiality of any information of the information contained in this Item 7.01, including Exhibit 99.1.

 

Item 8.01 Other Events.

 

In connection with the BCA Proposal, Waldencast’s shareholders elected to redeem an aggregate of approximately 30,021,946 Waldencast Class A ordinary shares.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit No.   Description
99.1   Press Release, dated  July 25, 2022
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

6

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Waldencast Acquisition Corp.
       
Date: July 25, 2022 By:  /s/ Michel Brousset
    Name:  Michel Brousset
    Title: Chief Executive Officer

 

 

7

 

 

 EX-99.1 2 ea163327ex99-1_walden.htm PRESS RELEASE, DATED JULY 25, 2022

Exhibit 99.1

 

 

Waldencast Acquisition Corp. Shareholders Approve Business Combination with Obagi Skincare and Milk Makeup

 

●The business combination with Obagi Skincare and Milk Makeup is expected to close on or around July 27, 2022
   
●Strong support from shareholders with approximately 98% approval
   
●The post-closing combined company will be renamed Waldencast plc and is expected to begin trading on Nasdaq under the ticker “WALD” on the first trading day following the closing date

 

JULY 25, 2022 – NEW YORK, NY – Waldencast Acquisition Corp., (NASDAQ: WALD) (“Waldencast”), a special purpose acquisition company, announced that in its extraordinary general meeting held today, its shareholders voted to approve the business combination with leading physician-dispensed, results-driven skin care brand Obagi Global Holdings Limited (“Obagi Skincare”) and award-winning makeup and skin care brand Milk Makeup LLC (“Milk Makeup”).

 

The business combination was supported by approximately 98% of the vote cast at the meeting, representing approximately 70% of Waldencast’s outstanding shares.

 

The closing of the business combination is expected to occur on or around July 27, 2022, subject to the satisfaction or waiver of all closing conditions. Upon the closing of the transactions with Obagi Skincare and Milk Makeup, both companies will become part of the Waldencast portfolio, and the combined company, Waldencast plc, will be listed on Nasdaq under the symbol “WALD”.

 

This three-way transaction with Obagi Skincare and Milk Makeup is a first step in Waldencast’s strategy to create a global best-in-class multi-brand beauty and wellness platform.

 

About Obagi Skincare

 

Obagi Skincare is an industry-leading, advanced skin care line rooted in research and skin biology, refined with a legacy of 30 years’ experience. First known as leaders in the treatment of hyperpigmentation with the Obagi Nu-Derm® System, Obagi Skincare products are designed to diminish the appearance of premature aging, photodamage, skin discoloration, acne, and sun damage. More information about Obagi Skincare is available on the brand’s website, Facebook, Twitter and Instagram pages.

 

About Milk Makeup

 

Founded in 2016 by Mazdack Rassi, Dianna Ruth, Georgie Greville, and Zanna Roberts Rassi, Milk Makeup quickly became a cult-favorite among the beauty community for its values of self-expression and inclusion, captured by its signature Live Your Look, its innovative formulas and clean ingredients. The brand creates vegan, cruelty-free, clean formulas from its Milk Makeup HQ in Downtown NYC. Currently, Milk Makeup offers over 300 products through its US website www.MilkMakeup.com, and its retail partners including Sephora in North America, Europe, the Middle East and Australia and Cult Beauty and Selfridges in the UK.

 

 

 

 

About Waldencast

 

Founded by Michel Brousset and Hind Sebti, Waldencast’s vision is to build a global best-in-class beauty and wellness operating platform by developing, acquiring, accelerating, and scaling the next generation of conscious, purpose-driven brands.  Waldencast entered into agreements regarding its proposed business combination with Obagi Skincare and Milk Makeup as a first step in realizing its vision. Waldencast intends to seek brands with a direct connection to today’s evolving consumers whose goals include pursuing social responsibility, inclusiveness, sustainability, and transparency. Its goal is to become the partner of choice for next-generation brands and consumers by leveraging the collective leadership and the industry-specific operating experience of its management team. 

 

Forward-Looking Statements

 

This press release contains certain forward-looking statements within the meaning of the federal securities laws, including with respect to the proposed transactions among Obagi Skincare, Milk Makeup and Waldencast, including statements regarding the intended benefits of the transactions, the anticipated timing of the transactions and the growth strategies of Waldencast, Obagi Skincare and Milk Makeup. These forward-looking statements generally are identified by the words “estimates,” “projects,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “would,” “should,” “future,” “propose,” “target,” “goal,” “objective,” “outlook” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the control of Waldencast, Obagi Skincare, and Milk Makeup, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Important factors, among others, that may affect actual results or outcomes include, but are not limited to: (i) the risk that the transactions may not be completed in a timely manner or at all, which may adversely affect the price of Waldencast’s securities, (ii) the inability to recognize the anticipated benefits of the proposed transactions (iii) the failure to receive certain governmental and regulatory approvals, (iv) the inability to complete the PIPE Investment or the Forward Purchase Agreements investments (as such terms are defined in the definitive proxy statement/prospectus filed by Waldencast with the SEC on July 7, 2022 (the “definitive proxy statement/prospectus”)), (v) the occurrence of any event, change or other circumstance that could give rise to the termination of the Obagi Merger Agreement or the Milk Equity Purchase Agreement (as such terms are defined in the definitive proxy statement/prospectus), (vi) changes in general economic conditions, including as a result of the COVID-19 pandemic, (vii) the outcome of litigation related to or arising out of the proposed transactions, or any adverse developments therein or delays or costs resulting therefrom, (viii) the effect of the announcement or pendency of the transactions on Obagi Skincare’s or Milk Makeup’s business relationships, operating results, and businesses generally, (ix) the ability to continue to meet Nasdaq’s listing standards following the consummation of the proposed transactions, (x) costs related to the proposed transactions, (xi) that the price of Waldencast’s securities may be volatile due to a variety of factors, including Waldencast’s, Obagi Skincare’s or Milk Makeup’s inability to implement their business plans or meet or exceed their financial projections and changes in the combined capital structure, (xii) the ability to implement business plans, forecasts, and other expectations after the completion of the proposed transactions, and identify and realize additional opportunities and (xiii) the ability of Obagi Skincare and Milk Makeup to implement their strategic initiatives and continue to innovate their existing products and anticipate and respond to market trends and changes in consumer preferences. The foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” section of Waldencast’s definitive proxy statement/prospectus and other documents filed or that may be filed by Waldencast from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and Obagi Skincare, Milk Makeup and Waldencast assume no obligation and do not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. Neither Waldencast, Obagi Skincare, or Milk Makeup gives any assurance that Waldencast, Obagi Skincare or Milk Makeup, or the combined company, will achieve their expectations.

 

Contacts

 

Investors

ICR

Allison Malkin

waldencastir@icrinc.com

 

Media

ICR

Brittany Fraser

Waldencast@icrinc.com

 

 

 

 

 

 GRAPHIC 3 ex99-1_001.jpg GRAPHIC begin 644 ex99-1_001.jpg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

1^X^WAM^]>F/3 M.:]KHHH0'BWQ5TF^O?&EK-;P;XQ;1@G>HYW-ZFO::** .#^(/P^'BE5O[!DB MU*)=OS<+*O8$]B.QKSD^-_&OA,?V5=SH6C&U1.%E91[,#S^.:**&!T7@_1O& M>M^(H/$>H:DT$*\%F=6\Q,\H$' !]\>M>O21I+&T)>( M_ NM^#M5?6O#EPPM%)8%9 KQ ]5(/##\_<55L?&7CKQ>?[*L)X@[#:[QA8S@ M]R3_ $YHHI"(I/ U_P"'O&^BP@BY42V\TDH8 9\SYL G/&*]^HHH0SQO7;3Q MQX/UJ]UJUOUN[2XG&>***!'KW@KPR/"GAV/3VD$D[,99G'0N<#CV 'X5JZKI\6K:5=:?/_J[ MB)HV([9'6BBF,\!D?Q1\,-4GABF2-)^_RNDH'1L=0>OI7I'PXD\6WL]UJ>MW <"O8W2@QJS D,.A4+PHQU'THHI"/0J***8S__V0$! end EX-101.SCH 4 wald-20220725.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 5 wald-20220725_def.xml XBRL DEFINITION FILE EX-101.LAB 6 wald-20220725_lab.xml XBRL LABEL FILE Class of Stock [Axis] Units, each consisting of one Class A ordinary share, par value $0.0001, and one-third of one redeemable warrant Class A ordinary shares, par value $0.0001 per share Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 Statement [Table] Statement [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 7 wald-20220725_pre.xml XBRL PRESENTATION FILE XML 8 R1.htm IDEA: XBRL DOCUMENT v3.22.2
Cover
Jul. 25, 2022
Document Type 8-K
Amendment Flag false
Document Period End Date Jul. 25, 2022
Entity File Number 001-40207
Entity Registrant Name Waldencast Acquisition Corp.
Entity Central Index Key 0001840199
Entity Tax Identification Number 98-1575727
Entity Incorporation, State or Country Code E9
Entity Address, Address Line One 10 Bank Street
Entity Address, Address Line Two Suite 560
Entity Address, City or Town White Plains
Entity Address, State or Province NY
Entity Address, Postal Zip Code 10606
City Area Code 917
Local Phone Number 546-6828
Written Communications true
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
Units, each consisting of one Class A ordinary share, par value $0.0001, and one-third of one redeemable warrant  
Title of 12(b) Security Units, each consisting of one Class A ordinary share, par value $0.0001, and one-third of one redeemable warrant
Trading Symbol WALDU
Security Exchange Name NASDAQ
Class A ordinary shares, par value $0.0001 per share  
Title of 12(b) Security Class A ordinary shares, par value $0.0001 per share
Trading Symbol WALD
Security Exchange Name NASDAQ
Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50  
Title of 12(b) Security Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
Trading Symbol WALDW
Security Exchange Name NASDAQ

XML 9 ea163327-8k425_walden_htm.xml IDEA: XBRL DOCUMENT 0001840199 2022-07-25 2022-07-25 0001840199 WALD:UnitsEachConsistingOfOneClassOrdinaryShareParValue0.0001AndOnethirdOfOneRedeemableWarrantMember 2022-07-25 2022-07-25 0001840199 WALD:ClassOrdinarySharesParValue0.0001PerShareMember 2022-07-25 2022-07-25 0001840199 WALD:RedeemableWarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50Member 2022-07-25 2022-07-25 iso4217:USD shares iso4217:USD shares 0001840199 false 8-K 2022-07-25 Waldencast Acquisition Corp. E9 001-40207 98-1575727 10 Bank Street Suite 560 White Plains NY 10606 917 546-6828 true false false false Units, each consisting of one Class A ordinary share, par value $0.0001, and one-third of one redeemable warrant WALDU NASDAQ Class A ordinary shares, par value $0.0001 per share WALD NASDAQ Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 WALDW NASDAQ true false EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2 html 4 24 1 false 3 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://waldencast.com/role/Cover Cover Cover 1 false false All Reports Book All Reports ea163327-8k425_walden.htm ea163327ex99-1_walden.htm wald-20220725.xsd wald-20220725_def.xml wald-20220725_lab.xml wald-20220725_pre.xml http://xbrl.sec.gov/dei/2022 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "ea163327-8k425_walden.htm": { "axisCustom": 0, "axisStandard": 1, "contextCount": 4, "dts": { "definitionLink": { "local": [ "wald-20220725_def.xml" ] }, "inline": { "local": [ "ea163327-8k425_walden.htm" ] }, "labelLink": { "local": [ "wald-20220725_lab.xml" ] }, "presentationLink": { "local": [ "wald-20220725_pre.xml" ] }, "schema": { "local": [ "wald-20220725.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 66, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 24, "memberCustom": 3, "memberStandard": 0, "nsprefix": "WALD", "nsuri": "http://waldencast.com/20220725", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "ea163327-8k425_walden.htm", "contextRef": "From2022-07-25to2022-07-25", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://waldencast.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "ea163327-8k425_walden.htm", "contextRef": "From2022-07-25to2022-07-25", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 3, "tag": { "WALD_ClassOrdinarySharesParValue0.0001PerShareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class A ordinary shares, par value $0.0001 per share" } } }, "localname": "ClassOrdinarySharesParValue0.0001PerShareMember", "nsuri": "http://waldencast.com/20220725", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "domainItemType" }, "WALD_RedeemableWarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50" } } }, "localname": "RedeemableWarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50Member", "nsuri": "http://waldencast.com/20220725", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "domainItemType" }, "WALD_UnitsEachConsistingOfOneClassOrdinaryShareParValue0.0001AndOnethirdOfOneRedeemableWarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Units, each consisting of one Class A ordinary share, par value $0.0001, and one-third of one redeemable warrant" } } }, "localname": "UnitsEachConsistingOfOneClassOrdinaryShareParValue0.0001AndOnethirdOfOneRedeemableWarrantMember", "nsuri": "http://waldencast.com/20220725", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r11", "r13", "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "booleanItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://waldencast.com/role/Cover" ], "xbrltype": "stringItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r10": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r11": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r12": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r13": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r14": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r15": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r16": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r17": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r18": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r19": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r9": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" } }, "version": "2.1" } ZIP 16 0001213900-22-041449-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-22-041449-xbrl.zip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end